*Sale of future Aphexda royalties
#$BLRX retains rights to future commercial milestone payments
*Proceeds will support GLIX1 development & partial loan repayment to Blackrock
*30Nov close
finance.yahoo.com/healthcare/a...
*Sale of future Aphexda royalties
#$BLRX retains rights to future commercial milestone payments
*Proceeds will support GLIX1 development & partial loan repayment to Blackrock
*30Nov close
finance.yahoo.com/healthcare/a...
*Call @ 8:30 am ET
*Access details in the PR
#$BLRX
finance.yahoo.com/healthcare/a...
*Call @ 8:30 am ET
*Access details in the PR
#$BLRX
finance.yahoo.com/healthcare/a...
https://www.stocktitan.net/news/BLRX/bio-line-rx-enters-into-5-6-million-royalty-monetization-transaction-98sthnofcjo8.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/BLRX/bio-line-rx-enters-into-5-6-million-royalty-monetization-transaction-98sthnofcjo8.html?utm_source=stocktitan-bluesky&utm_medium=social
*Brain PK/PD data
*Review preclinical data & describe Ph1/2 design
*Review antitumor activity of GLIX1
*Held 12-15Dec
#$BLRX
finance.yahoo.com/healthcare/a...
*Brain PK/PD data
*Review preclinical data & describe Ph1/2 design
*Review antitumor activity of GLIX1
*Held 12-15Dec
#$BLRX
finance.yahoo.com/healthcare/a...
https://www.stocktitan.net/news/BLRX/bio-line-rx-to-report-third-quarter-2026-results-on-november-23-0ojm590g3jx9.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/BLRX/bio-line-rx-to-report-third-quarter-2026-results-on-november-23-0ojm590g3jx9.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/BLRX/bio-line-rx-and-hemispherian-present-phase-1-2a-clinical-study-and-ivpj13dssxcr.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/BLRX/bio-line-rx-and-hemispherian-present-phase-1-2a-clinical-study-and-ivpj13dssxcr.html?utm_source=stocktitan-bluesky&utm_medium=social
prismmarketview.com/biolinerx-an...
prismmarketview.com/biolinerx-an...
https://www.stocktitan.net/news/BLRX/bio-line-rx-and-hemispherian-present-preclinical-data-demonstrating-tm4s56v608r6.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/BLRX/bio-line-rx-and-hemispherian-present-preclinical-data-demonstrating-tm4s56v608r6.html?utm_source=stocktitan-bluesky&utm_medium=social
BioLineRx and Hemispherian are set to present preclinical and Phase 1/2a trial design data for their first-in-class cance…
Read more: https://embers.news/article/biolinerx-and-hemispherian-to-present-glix1-data-at-sno-meeting-442423
BioLineRx and Hemispherian are set to present preclinical and Phase 1/2a trial design data for their first-in-class cance…
Read more: https://embers.news/article/biolinerx-and-hemispherian-to-present-glix1-data-at-sno-meeting-442423
prismmarketview.com/biolinerx-an...
prismmarketview.com/biolinerx-an...
*2 abstracts accepted
*Addresses preclinical efficacy in orthotopic GBM models
*24-27Sep in Rome
#$BLRX
finance.yahoo.com/healthcare/a...
*2 abstracts accepted
*Addresses preclinical efficacy in orthotopic GBM models
*24-27Sep in Rome
#$BLRX
finance.yahoo.com/healthcare/a...
🔎 Read the full update:
➡️https://theminingnews.com/zacks-small-cap-research-blrx-new-glix1-data-touts-synergies/
#BioLineRx#BioLineRxI#BLRXA#GLIX1a#PARP #Olaparibt#Glioblastomao#GBM #Oncologys#CancerResearchT#ClinicalTrials#PhaseI
🔎 Read the full update:
➡️https://theminingnews.com/zacks-small-cap-research-blrx-new-glix1-data-touts-synergies/
#BioLineRx#BioLineRxI#BLRXA#GLIX1a#PARP #Olaparibt#Glioblastomao#GBM #Oncologys#CancerResearchT#ClinicalTrials#PhaseI
BioLineRx Ltd. entered into a securities purchase agreement on August 27, 2026, for a registered direct offering and concurrent private placement, raising approximately $3.75 million in gross proceeds.
🧵 continued ↓
BioLineRx Ltd. entered into a securities purchase agreement on August 27, 2026, for a registered direct offering and concurrent private placement, raising approximately $3.75 million in gross proceeds.
🧵 continued ↓
*Call @ 8:30 am ET
*GLIX1 in GBM Ph1/2a ongoing
*Aphexda royalty revenue of $0.3mm
#$BLRX
ir.biolinerx.com/news-release...
*Call @ 8:30 am ET
*GLIX1 in GBM Ph1/2a ongoing
*Aphexda royalty revenue of $0.3mm
#$BLRX
ir.biolinerx.com/news-release...
https://www.stocktitan.net/news/BLRX/bio-line-rx-reports-second-quarter-2026-financial-results-and-nk2itpp8i60f.html
https://www.stocktitan.net/news/BLRX/bio-line-rx-reports-second-quarter-2026-financial-results-and-nk2itpp8i60f.html